Steve Fordan

Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians

Steve Fordan, Imran Afridi, Andrew Garza, Roberto L. Collazo-Maldonado

Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians

Steve Fordan, Imran Afridi, Andrew Garza, Roberto L. Collazo-Maldonado

Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians

Steve Fordan, Imran Afridi, Andrew Garza, Roberto L. Collazo-Maldonado

us, au (code pays fourni par la source)

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann et autres

us, nl, de, pk, dk, se, gb, cn, jp (code pays fourni par la source)

The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

Mustafa Tosur, Mario A. Cleves, Jay M. Sosenko, Ingrid Libman et autres

us, gb, it, au, fi, se, nl, ca, Cameroun (code pays fourni par la source)

Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes

Taylor M. Triolo, Alexandra Fouts, Laura Pyle, Liping Yu et autres

us (code pays fourni par la source)

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp et autres

us, gb, au (code pays fourni par la source)

The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial

Uģis Gruntmanis, Steve Fordan, Hans K. Ghayee, Shuaib Abdullah et autres

us (code pays fourni par la source)